IUS:NSD-Invesco RAFI Strategic US ETF

ETF | Others | NSD

Last Closing Price

USD 25.45

Change

-0.05 (-0.20)%

Market Cap

USD 3.77M

Volume

0.02M

Average Target Price

N/A
Average Analyst Rating

N/A

STA Verdict

Verdict

About

The investment seeks to track the investment results (before fees and expenses) of the Invesco Strategic US Index (the underlying index). The fund generally will invest at least 80% of its total assets in securities that comprise the underlying index. It generally invests in all of the securities comprising its underlying index in proportion to their weightings in the underlying index. The underlying index is designed to measure the performance of equity securities issued by higher quality, large-business-sized companies designated as U.S. companies. The fund is non-diversified.

Inception Date: 12/09/2018

Primary Benchmark: Invesco Strategic US USD

Management Expense Ratio: 0.00 %

Market Stats

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Sectors

N/A

Top Regions

N/A

Valuation Growth & Performance

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-10-14 )

Largest Industry Peers for Others

Symbol Name Mer Price(Change) Market Cap
BNTX BioNTech SE 0.00 %

-1.07 (-7.74%)

N/A
FREQ Frequency Therapeutics, Inc 0.00 %

+0.36 (+2.77%)

N/A
HBT HBT Financial, Inc 0.00 %

-0.04 (-0.26%)

N/A
OPRT Oportun Financial Corporation 0.00 %

+0.02 (+0.13%)

N/A
VIE Viela Bio, Inc 0.00 %

-0.45 (-2.34%)

N/A
VIR Vir Biotechnology, Inc 0.00 %

-0.23 (-1.64%)

N/A
ALFC Alfacourse Inc 0.00 %

N/A

N/A
AMRQQ Alta Mesa Resources, Inc 0.00 %

-0.01 (-23.53%)

N/A
AMRWQ Alta Mesa Resources, Inc 0.00 %

N/A

N/A
BSML Invesco BulletShares (R) 2021 .. 0.00 %

N/A

N/A

ETFs Containing IUS

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Others)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.64% 73% C 68% D+
Dividend Return 0.51% 16% F 7% F
Total Return 17.15% 71% C- 66% D
Trailing 12 Months  
Capital Gain 5.17% 60% D- 69% D+
Dividend Return 1.12% 24% F 19% F
Total Return 6.29% 55% F 66% D
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 0.05% 33% F 41% F
Dividend Return 0.08% 3% F 2% F
Total Return 0.13% 15% F 35% F
Risk Return Profile  
Volatility (Standard Deviation) 0.72% 99% A+ 100% A+
Risk Adjusted Return 18.16% 24% F 45% F
Market Capitalization 3.77M 4% F 4% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.